Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. (2017)

First Author: Bruce DW
Attributed to:  Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci91816

PubMed Identifier: 28375154

Publication URI: http://europepmc.org/abstract/MED/28375154

Type: Journal Article/Review

Volume: 127

Parent Publication: The Journal of clinical investigation

Issue: 5

ISSN: 0021-9738